Prospective Thinking in Hormone-Responsive Breast Cancer

Completed · Not applicable · Has a placebo group

Conditions studied: Hormone Receptor Positive Malignant Neoplasm of Breast

In brief

One factor that limits the effectiveness of adjuvant hormone therapy for breast cancer is medication nonadherence. Adherence to long-term medication regimens requires valuation of temporally distant outcomes. Thus, interventions that improve valuation of the future, a phenomenon known as delay discounting, may improve medication adherence in breast cancer treatment and improve survival. This study will investigate the acute efficacy of a prospective thinking intervention (episodic future thinking) for reducing delay discounting and improving valuation of future health in breast cancer patients. Patients will engage in either episodic future thinking or a control condition during completion of delay discounting tasks in which they choose between immediate and delayed outcomes.

Key facts

Study ID

NCT03594578

Run by

Virginia Polytechnic Institute and State University

People needed

89

Starts

2018-08-01

Expected to finish

2019-09-20

Last updated by the study team

2019-10-01

Who can join

Age: 18 and older, up to 80. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Age 18-80 years
• Female
• Must have a history of hormone responsive breast cancer treated with curative intent and have been recommended/prescribed adjuvant HT (tamoxifen, anastrozole, letrozole or exemestane) by their physician.

You may not qualify if…

• Recurrent breast cancer
• Adjuvant hormone therapy is no longer medically appropriate/advisable
• Incapable/ without capacity to provide personal consent
• Suffers from cognitive or physical impairments which interfere with medication self- administration and/or participation in episodic thinking
• Receiving HT for metastatic disease

Where it is running

• Virginia Tech Carilion Research Institute — Roanoke, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.